Dr. Adnan Mjalli is an internationally recognized entrepreneur in the business of drug discovery and development of new medicines in the pharmaceutical and biotechnology industry. 
The work of Dr. Mjalli goes far beyond drug discovery and development. He is the founder of more than 20 other companies in many areas, including education, energy, agriculture, bioremediation, construction, development, real estate, commerce and finance. These companies focus on science, education, tourism, entertainment, technology and the advancement of human capital in developing countries.
 
Dr. Mjalli attended university in Jordan and postgraduate studies in London, England before obtaining his PhD in Medicinal Chemistry in 1989 from the University of Exeter, UK. His postdoctoral work was completed at the University of Rochester with Professor Richard S. Schlessinger. Since then, Dr. Mjalli has held various positions of increasing leadership responsibilities in research and senior executive management at a number of pharmaceutical and biotechnology companies, including Merck & Co., Inc..
 
During the early stages of his leadership responsibilities he was successful in raising close to $1 billion dollars in equity and forged major strategic partnerships with several pharmaceutical and biotechnology companies including Merck & Co., Pfizer, Novo Nordisk, Boehringer Ingelheim, Kanabo Pharmaceuticals of  Japan, Cephalon (acquired by Teva), and Forest Labs (acquired by Actavis)

So far, Dr. Mjalli has authored hundreds of scientific articles, four book chapters, and has been named an inventor on over 700 patents and patent applications. 
 
Dr. Mjalli has also served on the Board of Directors of Siga Technologies, North Carolina Biotechnology Center, Guilford Technology Community College (GTCC) and High Point Economic Development Corporation. Currently, Dr. Mjalli serves on the High Point University Board, the Arab American University, the American Task Force on Palestine, the America-Mideast Education and Training Service, Inc. (AMIDEAST), and is a Member of the American Chemical Society since 1998, a member of the Board of Al-Quds University and chairman of the Advisory Board of Al-Quds Bard College.